Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- A treating doctor has decided, based on Korean prescribing guidelines, that the person is due to start treatment with Talzenna® (talazoparib).
- The person (or their legal representative) has signed and dated a consent form, showing they have been fully informed about all aspects of the study.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a known allergic reaction or sensitivity to Talzenna® or any of its ingredients.
- People who are currently breastfeeding.
- People (or their legal representative) who do not agree to Pfizer and its partners using their personal information for this study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Incidence of adverse events categorized according to physical organ and disease/symptom
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.